Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
Supply of generic and biosimilar transition medicines to NHS Scotland.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Accord Healthcare Ltd | 04596349 | ~£118,856,406 estimated from lot values | 6 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Denosumab (Osteoporosis) and Ferric Carboxymaltose · Apremilast · Nintedanib · Cancer Medicines (Group 1) · Cancer Medicines (Group 2) | - |
| Amarox Limited | 10997632 | ~£26,183,523 estimated from lot values | 1 lot Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines | - |
| Amgen Ltd | 02354269 | ~£21,258,752 estimated from lot values | 1 lot Cancer Medicines (Group 2) | - |
| AOP Orphan Ltd | 08082765 | ~£26,183,523 estimated from lot values | 1 lot Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines | - |
| Biocon Pharma UK Ltd | 11716196 | ~£26,183,523 estimated from lot values | 1 lot Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines | - |
| Brown and Burk | - | ~£518,271 estimated from lot values | 2 lots Cardiovascular and Respiratory Medicines · Psychiatry and Neurology Medicines | - |
| Celix Pharma Ltd. | 12474195 | ~£55,459,461 estimated from lot values | 4 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Apremilast · Cardiovascular and Respiratory Medicines · Nintedanib | - |
| Celltrion Healthcare United Kingdom Limited | 11685363 | ~£164,273,518 estimated from lot values | 4 lots Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) · Cytokine Modulators (Omalizumab) · Denosumab (Osteoporosis) and Ferric Carboxymaltose · Cancer Medicines (Group 2) | - |
| Chiesi Limited | 02140985 | ~£26,183,523 estimated from lot values | 1 lot Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines | LOBBYIST Ovid Consulting Ltd (7 quarters) Hill & Knowlton Limited (4 quarters) Portland PR Limited (2 quarters) |
| CST Pharma Ltd | 04212740 | ~£457,484 estimated from lot values | 1 lot Cardiovascular and Respiratory Medicines | - |
| Dr Falk Pharma UK Ltd | 02307698 | ~£26,183,523 estimated from lot values | 1 lot Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines | - |
| Dr Reddy's Laboratories (UK) Ltd | 01729064 | ~£102,185,203 estimated from lot values | 4 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Denosumab (Osteoporosis) and Ferric Carboxymaltose · Nintedanib · Cancer Medicines (Group 2) | - |
| Ferring Pharmaceuticals Limited | 01198007 | ~£41,358,768 estimated from lot values | 2 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Cancer Medicines (Group 1) | DONOR£1.44M across 11 donations To: Liberal Democrats |
| Fresenius Kabi Ltd | 02182135 | ~£148,629,761 estimated from lot values | 3 lots Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) · Denosumab (Osteoporosis) and Ferric Carboxymaltose · Cancer Medicines (Group 2) | - |
| Gedeon Richter UK Ltd | 04325685 | ~£48,679,184 estimated from lot values | 2 lots Denosumab (Osteoporosis) and Ferric Carboxymaltose · Cancer Medicines (Group 2) | - |
| Glenmark Pharmaceuticals Europe Ltd | 05040260 | ~£41,358,768 estimated from lot values | 2 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Cancer Medicines (Group 1) | - |
| Janssen-Cilag Ltd | 01027904 | ~£99,950,577 estimated from lot values | 1 lot Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | LOBBYIST Ovid Consulting Ltd (4 quarters) |
| Lupin Healthcare UK Ltd | 06925119 | ~£60,787 estimated from lot values | 1 lot Psychiatry and Neurology Medicines | - |
| Mercury Pharmaceuticals Limited | 02619880 | ~£190,359,105 estimated from lot values | 5 lots Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) · Cytokine Modulators (Omalizumab) · Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Nintedanib · Cancer Medicines (Group 2) | - |
| MSN Labs | - | ~£26,183,523 estimated from lot values | 1 lot Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines | - |
| Perennial Pharma Ltd | 11826246 | ~£26,183,523 estimated from lot values | 1 lot Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines | - |
| Pfizer | 00526209 | ~£15,175,245 estimated from lot values | 1 lot Cancer Medicines (Group 1) | DONOR£41K across 4 donations To: Progressive Britain Ltd (formally Progress Ltd) LOBBYIST Portland PR Limited (20 quarters) Ovid Consulting Ltd (3 quarters) Hanover Communications International Limited (3 quarters) MHP Communications (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP John Austin— Gifts, benefits and hospitality from UK sources (former) |
| Roche Products Ltd | 00100674 | ~£99,950,577 estimated from lot values | 1 lot Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | LOBBYIST M&F Health (5 quarters) Ovid Consulting Ltd (2 quarters) |
| Samsung Bioepis Ltd | 08840722 | ~£48,679,184 estimated from lot values | 2 lots Denosumab (Osteoporosis) and Ferric Carboxymaltose · Cancer Medicines (Group 2) | - |
| Sandoz | 01547204 | ~£48,679,184 estimated from lot values | 2 lots Denosumab (Osteoporosis) and Ferric Carboxymaltose · Cancer Medicines (Group 2) | - |
| SERB SA | - | ~£26,183,523 estimated from lot values | 1 lot Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines | - |
| STADA UK - Thornton & Ross | - | ~£91,991,394 estimated from lot values | 6 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Denosumab (Osteoporosis) and Ferric Carboxymaltose · Apremilast · Cardiovascular and Respiratory Medicines · Cancer Medicines (Group 1) · Cancer Medicines (Group 2) | - |
| Takeda UK Limited | 03362860 | ~£26,183,523 estimated from lot values | 1 lot Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines | LOBBYIST Hill & Knowlton Limited (3 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (2 quarters) Burkitt Communications Ltd (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP Sir Kevin Barron— Employment and earnings (former) |
| Teva UK Ltd | 00302461 | ~£98,055,138 estimated from lot values | 6 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Denosumab (Osteoporosis) and Ferric Carboxymaltose · Apremilast · Cardiovascular and Respiratory Medicines · Nintedanib · Cancer Medicines (Group 1) | - |
| Viatris UK Healthcare Ltd | 09189103 | ~£26,183,523 estimated from lot values | 1 lot Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines | LOBBYIST Instinctif Partners Holdings Limited (1 quarter) |
| Vifor Pharma UK Limited | 06514784 | ~£27,420,432 estimated from lot values | 1 lot Denosumab (Osteoporosis) and Ferric Carboxymaltose | - |
| Wockhardt UK Limited | 05835570 | ~£53,506,019 estimated from lot values | 2 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Nintedanib | - |
| Zentiva UK | - | ~£64,311,913 estimated from lot values | 4 lots Denosumab (Osteoporosis) and Ferric Carboxymaltose · Cardiovascular and Respiratory Medicines · Cancer Medicines (Group 1) · Cancer Medicines (Group 2) | - |
| Zydus Pharmaceuticals UK Ltd | 14646636 | ~£26,641,007 estimated from lot values | 2 lots Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines · Cardiovascular and Respiratory Medicines | - |
This procurement was divided into 10 lots, each awarded separately. 420 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) Feb 2026 – Feb 2027 | £99,950,577 £26,539,272 initial term | 42 | Mercury Pharmaceuticals Limited Celltrion Healthcare United Kingdom Limited Fresenius Kabi Ltd Roche Products Ltd Janssen-Cilag Ltd | complete |
| Lot 2 Cytokine Modulators (Omalizumab) Apr 2026 – Feb 2027 | £15,643,757 £9,253,091 initial term | 42 | Mercury Pharmaceuticals Limited Celltrion Healthcare United Kingdom Limited | complete |
| Lot 3 Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines Feb 2026 – Jul 2027 | £26,183,523 £3,594,493 initial term | 42 | Mercury Pharmaceuticals Limited Accord Healthcare Ltd Amarox Limited AOP Orphan Ltd Biocon Pharma UK Ltd Celix Pharma Ltd. Chiesi Limited Dr Falk Pharma UK Ltd Dr Reddy's Laboratories (UK) Ltd Ferring Pharmaceuticals Limited Glenmark Pharmaceuticals Europe Ltd MSN Labs Perennial Pharma Ltd SERB SA Takeda UK Limited Teva UK Ltd STADA UK - Thornton & Ross Viatris UK Healthcare Ltd Wockhardt UK Limited Zydus Pharmaceuticals UK Ltd | complete |
| Lot 4 Denosumab (Osteoporosis) and Ferric Carboxymaltose Feb 2026 – Jul 2027 | £27,420,432 £2,254,091 initial term | 42 | Celltrion Healthcare United Kingdom Limited Fresenius Kabi Ltd Accord Healthcare Ltd Dr Reddy's Laboratories (UK) Ltd Teva UK Ltd STADA UK - Thornton & Ross Zentiva UK Gedeon Richter UK Ltd Samsung Bioepis Ltd Sandoz Vifor Pharma UK Limited | complete |
| Lot 5 Apremilast Feb 2026 – Oct 2027 | £1,495,958 £663,520 initial term | 42 | Accord Healthcare Ltd Celix Pharma Ltd. Teva UK Ltd STADA UK - Thornton & Ross | complete |
| Lot 6 Cardiovascular and Respiratory Medicines Feb 2026 – May 2028 | £457,484 £78,009 initial term | 42 | Brown and Burk Celix Pharma Ltd. Teva UK Ltd STADA UK - Thornton & Ross Zentiva UK Zydus Pharmaceuticals UK Ltd CST Pharma Ltd | complete |
| Lot 7 Nintedanib Apr 2026 – May 2028 | £27,322,496 £1,400,387 initial term | 42 | Celix Pharma Ltd. Dr Reddy's Laboratories (UK) Ltd Teva UK Ltd Wockhardt UK Limited Accord Healthcare Ltd Mercury Pharmaceuticals Limited | complete |
| Lot 8 Cancer Medicines (Group 1) Feb 2026 – Jan 2027 | £15,175,245 £1,925,364 initial term | 42 | Accord Healthcare Ltd Ferring Pharmaceuticals Limited Glenmark Pharmaceuticals Europe Ltd Teva UK Ltd STADA UK - Thornton & Ross Zentiva UK Pfizer | complete |
| Lot 9 Cancer Medicines (Group 2) Feb 2026 – Jan 2027 | £21,258,752 £18,207,081 initial term | 42 | Mercury Pharmaceuticals Limited Celltrion Healthcare United Kingdom Limited Fresenius Kabi Ltd Accord Healthcare Ltd Dr Reddy's Laboratories (UK) Ltd STADA UK - Thornton & Ross Zentiva UK Gedeon Richter UK Ltd Samsung Bioepis Ltd Sandoz Amgen Ltd | complete |
| Lot 10 Psychiatry and Neurology Medicines Feb 2026 – Sept 2028 | £60,787 £188,432 initial term | 42 | Brown and Burk Lupin Healthcare UK Ltd | complete |
Weightings from the notice, applied to every lot.
Government spending data: These suppliers have received £632,132,931 in 7,457 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care, NHS Supply Chain (DHSC-funded), NHS England, Manchester University NHS Foundation Trust and 20 more public bodies (2010-05-13 to 2026-03-31).
Changes the buyer published to this notice after it first appeared.
1) Invitation to Tender published later than expected. Adjustment to deadline to meet minimum timescale requirement.
2) Lot 7 start date changed to avoid originator marketing exclusivity infringement.
Published by the buyer on this notice. Check the original notice — details change and are not updated here.